The Protein and Molecular and Molecular Biology Core of this Program Project will operate within the existing facilities of the Rheumatic Diseases Division to support the research activities of Program investigators. The research programs proposed by these investigators have common requirements for preparation for reagents, distribution of supplies, synthesis and analysis of nucleic acids, expression of purified proteins and generation of recombinant DNA for in vitro gene transfer experiments and generation of transgenic mice. The Core will consist of a Director, a Research Scientist, and Research Technician. The Core facilities will include a DNA Synthesizer, and Automated DNA Sequencer, long-term tissue culture facilities, and a laboratory for the preparation and purification of recombinant DNA and proteins. The programs and services provided by the Core will be: 1. DNA Synthesis and Sequencing 2. Hybridoma Protein Production 3. Recombinant Protein Production Close collaboration between the Core and the principal investigators for the individual projects will be maintained in order to optimize their research productivity through utilization of Core services. In this way, wasteful redundancy will be avoided, and research reagents will be provided at reduced costs. This will allow centralization of uncommonly used techniques, resulting in better quality control, more rapid throughput.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
2P01AI031229-08A1
Application #
6099501
Study Section
Project Start
1998-09-30
Project End
1999-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
City
Dallas
State
TX
Country
United States
Zip Code
75390
Nashi, Emil; Wang, YingHua; Diamond, Betty (2010) The role of B cells in lupus pathogenesis. Int J Biochem Cell Biol 42:543-50
Tao, Xuelian; Fan, Fred; Hoffmann, Victoria et al. (2008) Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. Arthritis Rheum 58:1774-83
Dorner, T; Lipsky, P E (2005) Molecular basis of immunoglobulin variable region gene usage in systemic autoimmunity. Clin Exp Med 4:159-69
Ramanujam, Meera; Davidson, Anne (2004) The current status of targeting BAFF/BLyS for autoimmune diseases. Arthritis Res Ther 6:197-202
Dorner, Thomas; Lipsky, Peter E (2002) Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjogren's syndrome. Arthritis Res 4:360-71
Dorner, Thomas; Hansen, Arne; Jacobi, Annett et al. (2002) Immunglobulin repertoire analysis provides new insights into the immunopathogenesis of Sjogren's syndrome. Autoimmun Rev 1:119-24
Girschick, Hermann J; Grammer, Amrie C; Nanki, Toshihiro et al. (2002) Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum 46:1255-63
Schiffer, L E; Hussain, N; Wang, X et al. (2002) Lowering anti-dsDNA antibodies--what's new? Lupus 11:885-94
Girschick, Hermann J; Lipsky, Peter E (2002) The kappa gene repertoire of human neonatal B cells. Mol Immunol 38:1113-27
Huang, Weiqing; Sinha, Jayashree; Newman, Jeffrey et al. (2002) The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus. Arthritis Rheum 46:1554-62

Showing the most recent 10 out of 53 publications